title: [Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis].
authors.affiliation: Sclerose Forskningsenheden, Københavns MS Center, Neurologisk Afdeling 2082, H:S Rigshospitalet. pss@rh.dk
authors.forename: Soelberg
authors.initials: S
authors.lastname: Sørensen
authors.forename: Nils J
authors.initials: NJ
authors.lastname: Koch-Henriksen
authors.forename: Christian Ross
authors.initials: CR
authors.lastname: Pedersen
authors.forename: Katja Maria
authors.initials: KM
authors.lastname: Clemmesen
authors.forename: Klaus
authors.initials: K
authors.lastname: Bendtzen
authors.forename: Jette Lautrup
authors.initials: JL
authors.lastname: Frederiksen
authors.forename: Kai
authors.initials: K
authors.lastname: Jensen
authors.forename: Ole
authors.initials: O
authors.lastname: Kristensen
authors.forename: Thor
authors.initials: T
authors.lastname: Petersen
authors.forename: Søren
authors.initials: S
authors.lastname: Rasmussen
authors.forename: Mads
authors.initials: M
authors.lastname: Ravnborg
authors.forename: Egon
authors.initials: E
authors.lastname: Stenager
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000276:immunology*; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000276:immunology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy / Q000276:immunology*; D009500:Neutralization Tests; D011446:Prospective Studies
chemical_list: D000276:Adjuvants, Immunologic; D000906:Antibodies; D016899:Interferon-beta